What is BPC-157 classified as?
BPC-157 is described in the research literature as a synthetic 15-amino-acid peptide, also known as a gastric pentadecapeptide.
Classification: Synthetic 15-amino-acid peptide, also called a gastric pentadecapeptide in the research literature.
BPC-157 is a synthetic 15-amino-acid peptide. Research records also call it body protection compound 157, BPC 157, PL 14736, or stable gastric pentadecapeptide. Those names describe a research substance and should not be used to infer that every label has the same sequence, salt, purity, or formulation.
The calculator has a narrow purpose: it translates visitor-entered mass and liquid-volume values into concentration, represented mL, and a syringe display position. It does not evaluate a vial, select an amount, or convert an experimental observation into a personal decision.
Concentration is dependent on liquid volume. The entered mass stays the numerator while the entered mL value is the denominator, so changing the volume changes the arithmetic concentration. A syringe scale measures liquid volume; mass cannot be recovered from its units without that concentration.
An early PubMed record studied BPC-157 in experimental liver-lesion models and explicitly described it as a 15-amino-acid peptide. Later publications and reviews cover additional animal models and summarize proposed biological mechanisms.
A systematic review of orthopaedic sports-medicine literature reported that the available body of work is dominated by preclinical studies and that human efficacy remains unconfirmed. This is a limitation of the evidence base, not a prediction about future research.
FDA’s July 2026 advisory-committee notice lists BPC-157 free base and BPC-157 acetate among bulk drug substances being considered for the 503A Bulks List. A meeting and a nomination are not the same as approval.
The linked PubMed records support identity and research context. They do not establish a product authorization, a validated indication, or a conclusion about an individual.
Enter mass in mg or mcg. Normalization uses 1 mg = 1,000 mcg, with no compound-specific conversion.
Concentration is normalized mass divided by liquid volume in mL. Represented mL is the entered mass divided by concentration, subject to validation.
U-100 means 100 units per mL and U-40 means 40 units per mL. They are syringe display scales, not BPC-157 properties and not recommendations.
The same displayed syringe units can correspond to different mL values on different scales. Concentration is required before relating a volume-scale position to mass.
BPC-157 is described in the research literature as a synthetic 15-amino-acid peptide, also known as a gastric pentadecapeptide.
No. PepLedger does not determine or recommend an amount. It performs arithmetic using values entered by the visitor.
Concentration is the entered mass divided by the entered liquid volume. Changing that denominator changes the calculated concentration.
No conclusion of that kind is made here. Much of the cited literature is preclinical, and experimental findings do not establish a human clinical outcome.
U-40 means 40 units per mL as a display scale. It does not describe BPC-157 or provide a use instruction.
No. The cited FDA notice concerns advisory-committee consideration of bulk substances, which is distinct from approval.
PepLedger calculates concentration, liquid volume and syringe-scale position exclusively from the values you enter. It does not choose or recommend an amount.
View our calculation methodology and editorial standards
Last updated: September 13, 2026